What is Preterm Labor Treatment Market?
Preterm labor is when your body starts getting ready for birth too early in your pregnancy. Labor is premature if it starts more than 3 weeks before your due date.A typical pregnancy lasts roughly 40 weeks. Having had a previous premature birth and being pregnant with multiples are two risk factors for premature birth. Immature lungs, trouble regulating body temperature, poor eating, and delayed weight gain are all complications of premature delivery. Premature babies may require additional nursery care, medication, and, in certain cases, surgery. There has been a gradual increase in the number of preterm births in the last few years. The Preterm Birth Prevention and Management includes various therapies which prevent and manage preterm birth. A Preterm Birth Diagnostic Test Kit aids in the detection of preterm labor and the possibility of premature membrane rupture. The increased emphasis on cost-effective diagnosis for detecting preterm birth is attributed to the market growth
The market study is being classified by Type (Devices, Cervical Cerclage, Vaginal Pessaries and Drug), by Application (Hospitals, Pediatric and Neonatal Clinics, Nursing Homes and Pharmacy) and major geographies with country level break-up.
AbbVie Inc. (United States), Allergan (Ireland), AMAG Pharmaceuticals (United States), Bayer AG (Germany), Ferring B.V. (Switzerland), Merck & Co. Inc. (United States), Mylan N.V. (United States), Pfizer Inc. (United States), CooperSurgical, Inc. (United States) and Teva Pharmaceutical Industries Ltd. (Israel) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are IQ Products (Netherlands), Medgyn Products (United States), Anhui Deep Blue Medical Technology (China) and Nanjing Liming Biological Preparations Co Ltd (China).
Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Preterm Labor Treatment market throughout the predicted period.
Analyst at AMA have segmented the market study of Global Preterm Labor Treatment market by Type, Application and Region.
On the basis of geography, the market of Preterm Labor Treatment has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
- Increasing Need for Preterm Birth Prevention and Management Drugs
- Growing Demand for Cost Effective Diagnosis of Preterm Births
- Growing Focus on Targeted Therapies and Standard of Care
- Rapid Preterm Birth Diagnostic Test Kits
- Adverse Effects Associated with Medication
- Lack of Awareness about Treatment
- Promotional Activities to Increase Awareness
- Growth Opportunities in Untapped Markets in the Developing Countries
- Stringent Regulatory Factors for Drugs and Devices
May 2020 – U.S. Food and Drug Administration’s Center for Drug Evaluation and Research (CDER) proposed that Makena (hydroxyprogesterone caproate injection) be withdrawn from the market because the required postmarket study failed to verify clinical benefit and we have concluded that the available evidence does not show Makena is effective for its approved use.
Preterm Labor Treatment devices require the FDA Pre Market Approval. The applicant must receive FDA approval of its PMA application prior to marketing the device. PMA approval is based on a determination by FDA that the PMA contains sufficient valid scientific evidence to assure that the device is safe and effective for its intended use
Key Target Audience
Pharmaceutical Companies, Healthcare Industry, Regulatory Bodies and Others
Frequently Asked Questions (FAQ):1. Which factors would majorly drive the Preterm Labor Treatment Market?
"Increasing Need for Preterm Birth Prevention and Management Drugs
" is seen as one of major growth factors of Preterm Labor Treatment Market in years to come.2. Can we have customized study for Preterm Labor Treatment Market?
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.